Rocky Mountain Spotted Fever — When Doxycycline Has Failed or Cannot Be Used

This protocol covers Rocky Mountain spotted fever (RMSF) in the specific situation where first-line treatment with doxycycline has not produced the expected clinical response, or where doxycycline cannot be used.

First-Line Failure Condition

Doxycycline is the established first-line treatment for RMSF. The expected outcome is fever resolution within 24 to 48 hours of starting therapy. This protocol is indicated when that response is not achieved, or when a severe doxycycline allergy makes its use untenable.

Next-Step Approach (Partial Overview)

When doxycycline cannot be continued or tolerated, the management options include inpatient procedures that may allow doxycycline therapy to proceed despite allergy, as well as a very limited set of alternative antibiotic agents. Full selection criteria, clinical guidance, and sequencing details are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

In cases of severe doxycycline allergy, rapid desensitization procedures in an inpatient setting may be considered.

Chloramphenicol is the only alternative drug used to treat RMSF; however, epidemiologic studies suggest that RMSF patients treated with chloramphenicol are at higher risk for death than people who received a tetracycline-class antibiotic.

View source ↗